Immuneering (IMRX) Sees Pre-Market Boost As Stock Climbs On Trial Data
Upon sharing encouraging early responder results from current clinical study has caused a notable spike in Immuneering Corporation (NASDAQ: IMRX) stock price. As of the most recent pre-market check, IMRX shares had surged 47.55% to $2.11, after closing at $1.43 the previous session with a 10.85% gain. This increase is a reflection of increased investor optimism […]
Immuneering (IMRX) Sees Pre-Market Boost As Stock Climbs On Trial Data Read More »